Gliclazide(CAS: 21187-98-4)

Gliclazide is a chemical compound with the CAS number 21187-98-4. It is a derivative of thiazolidinedione and is primarily known for its use as an oral antidiabetic medication. Gliclazide has a molecular formula of C11H12N2O3S and is characterized by its ability to improve insulin sensitivity and lower blood glucose levels in patients with type 2 diabetes.

Gliclazide is mainly used in the treatment of type 2 diabetes to help regulate blood sugar levels. It works by increasing the body's sensitivity to insulin, thereby enhancing glucose uptake. Additionally, it is used in research settings to study metabolic disorders and has potential applications in pharmaceutical development for diabetes management.

Gliclazide is generally considered safe when used as directed under medical supervision. However, like all medications, it may have side effects such as hypoglycemia, weight gain, or gastrointestinal discomfort. Proper handling and adherence to safety guidelines are essential to minimize risks. It is approved by regulatory bodies for therapeutic use and meets safety standards in pharmaceutical formulations.

Gliclazide should be stored in a cool, dry place, away from light and moisture. It is typically kept in a sealed container at a temperature between 15°C and 30°C. Proper storage ensures stability and prevents degradation, maintaining its efficacy and safety for use in diabetes treatment.